202 related articles for article (PubMed ID: 26307822)
1. Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme.
Shi K; Zhou J; Zhang Q; Gao H; Liu Y; Zong T; He Q
J Biomed Nanotechnol; 2015 Mar; 11(3):382-91. PubMed ID: 26307822
[TBL] [Abstract][Full Text] [Related]
2. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.
Yang Z; Tang W; Luo X; Zhang X; Zhang C; Li H; Gao D; Luo H; Jiang Q; Liu J
J Biomed Nanotechnol; 2015 Aug; 11(8):1401-17. PubMed ID: 26295141
[TBL] [Abstract][Full Text] [Related]
3. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
4. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
[TBL] [Abstract][Full Text] [Related]
5. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
Yang Z; Luo X; Zhang X; Liu J; Jiang Q
Biomed Mater; 2013 Apr; 8(2):025012. PubMed ID: 23507576
[TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
8. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting.
Chu L; Wang A; Ni L; Yan X; Song Y; Zhao M; Sun K; Mu H; Liu S; Wu Z; Zhang C
Drug Deliv; 2018 Nov; 25(1):1634-1641. PubMed ID: 30176744
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth.
Chung K; Ullah I; Kim N; Lim J; Shin J; Lee SC; Jeon S; Kim SH; Kumar P; Lee SK
J Drug Target; 2020 Jul; 28(6):617-626. PubMed ID: 31852284
[TBL] [Abstract][Full Text] [Related]
11. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
12. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
[TBL] [Abstract][Full Text] [Related]
14. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging.
Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP
Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997
[TBL] [Abstract][Full Text] [Related]
15. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
Song S; Mao G; Du J; Zhu X
Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X
Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723
[TBL] [Abstract][Full Text] [Related]
17. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
18. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles.
Sousa F; Dhaliwal HK; Gattacceca F; Sarmento B; Amiji MM
J Control Release; 2019 Sep; 309():37-47. PubMed ID: 31344424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
